Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,400
+800 (1.28%)
At close: Oct 28, 2025
1.28%
Market Cap485.99B
Revenue (ttm)12.16B
Net Income (ttm)2.57B
Shares Out8.13M
EPS (ttm)-273.00
PE Ratio188.78
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume63,924
Average Volume73,460
Open64,000
Previous Close62,600
Day's Range62,600 - 65,100
52-Week Range27,250 - 86,500
Betan/a
RSI38.20
Earnings Daten/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.